Parkwood LLC’s Zimmer Biomet ZBH Stock Holding History

Parkwood LLC’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-3,526	Closed	-$353K	–	553
2016 Q4	$353K	Buy	3,526 +1,297	+58%	+$139K	0.05%	256
2016 Q3	$281K	Buy	+2,229	New	+$275K	0.04%	361

Other funds holding ZBH

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Parkwood LLC's ZBH Position: Q1 2017 in Review

Parkwood LLC sold out of Zimmer Biomet (ZBH) in Q1 2017, closing a stake of 3,526 shares — an estimated $353K sold.

Parkwood LLC first reported a position in ZBH in Q3 2016 and held it in 2 quarters. The position peaked at $353K in Q4 2016. 817 funds tracked by Wall St. Rank hold ZBH as of Q1 2017.

Parkwood LLC reported no remaining Zimmer Biomet position as of Q1 2017 after selling out during the quarter.
Parkwood LLC sold 3,526 Zimmer Biomet shares in Q1 2017, an estimated $353K.
Parkwood LLC first reported a position in Zimmer Biomet in Q3 2016 and held it in 2 quarters.
Parkwood LLC's Zimmer Biomet position peaked at $353K in Q4 2016.
817 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2017.

Based on Parkwood LLC's 13F filing for Q1 2017, filed 5 May 2017.